NCT01378871 2023-06-09A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/LymphomaAlbert Einstein College of MedicinePhase 2 Terminated1 enrolled 8 charts